Heterogeneity of linear B cell epitopes of the measles virus fusion protein reacting with late convalescent sera

References

1. Albrecht P., Ennis F. A., Saltzman E. J., Krugman S. 1977; Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. Journal of Pediatrics 91:715–719
   [Google Scholar]
2. Barnett B. C., Burt D. S., Graham C. M., Warren A. P., Skehel J. J., Thomas D. B. 1989; I-Ad-restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit. Journal of Immunology 143:2663–2669
   [Google Scholar]
3. Black F. L. 1989; Measles active and passive immunity in a worldwide perspective. Progress in Medical Virology 36:1–33
   [Google Scholar]
4. Buckland R., Gerald C., Barker R., Wild T. F. 1987; Fusion glycoprotein of measles virus: nucleotide sequence of the gene and comparison with other paramyxoviruses. Journal of General Virology 68:1695–1703
   [Google Scholar]
5. Frank H., Nicholson G. J., Bayer E. 1978; Enantiomer labelling, a method for the quantitative analysis of amino acids. Journal of Chromatography 167:187–196
   [Google Scholar]
6. Garnier J., Osguthorpe D. J., Robson B. J. 1978; Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular protein. Journal of Molecular Biology 120:97–120
   [Google Scholar]
7. Giraudon P., Wild T. F. 1985; Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144:46–58
   [Google Scholar]
8. Graham C. M., Barnett B. C., Hartmayr I., Burt D. S., Faulkes R., Skehel J. J., Thomas D. B. 1989; The structural requirements for class II (I-Ad)-restricted T cell recognition of influenza hemagglutinin: B cell epitopes define T cell epitopes. European Journal of Immunology 19:523–528
   [Google Scholar]
9. Hopp T. P. 1981; Protein antigen conformation: folding patterns and predictive algorithms; selection of antigenic and immunogenic peptides. Annali Sclavo 2:47–60
   [Google Scholar]
10. Hopp T. P., Woods K. R. 1981; Prediction of protein antigenic determinants from amino acid sequence. Proceedings of the National Academy of Sciences, U.S.A. 79:3824–3828
    [Google Scholar]
11. Janeway C. A. 1945; Use of concentrated human serum gamma globulin in the prevention and attenuation of measles. Bulletin of the New York Academy of Medicine 21:202–222
    [Google Scholar]
12. Kyte J., Doolittle R. F. 1982; A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157:105–132
    [Google Scholar]
13. Makela M. J., Marusyk R. G., Norrby E., Tyrrell D. L. J., Salmi A. A. 1989; Antibodies to measles virus surface polypeptides in an immunized student population before and after booster vaccination. Vaccine 7:541–545
    [Google Scholar]
14. Malvoisin E., Wild F. 1990; Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. Journal of Virology 64:5160–5162
    [Google Scholar]
15. Merz D., Scheid A., Choppin P. W. 1980; The importance of antibody to fusion protein of paramyxoviruses in the prevention of spread of infection. Journal of Experimental Medicine 151:275–288
    [Google Scholar]
16. Norrby E., Enders-Ruckle G., ter Meulen V. 1975; Differences in the appearances of antibodies to structural components of measles after immunization with inactivated and live virus. Journal of Infectious Diseases 132:262–269
    [Google Scholar]
17. Parker J. M. R., Hodges R. S. 1991; Prediction of surface and interior regions in proteins. Part I: Linear tripeptide sequences identify structural boundaries in proteins. Peptide Research 4:347–354
    [Google Scholar]
18. Partidos C. D., Steward M. W. 1990; Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. Journal of General Virology 71:2099–2105
    [Google Scholar]
19. Partidos C. D., Stanley C. M., Steward M. W. 1991; Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins. Journal of General Virology 72:1293–1299
    [Google Scholar]
20. Richardson C. D., Hull D., Green P., Hasel K., Berkovids A., Englund G., Bellini W. J., Rima B., Lazzarini R. A. 1986; The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology 155:508–523
    [Google Scholar]
21. Richardson C. D., Scheid A., Choppin P. W. 1980; Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of F1 or HA2 viral polypeptides. Virology 105:205–222
    [Google Scholar]
22. Rossi P., Moschese V., Broliden P. A., Fundaró C., Quinti I., Plebani A., Giaquinto C., Tovo P. A., Ljunggren K., Rosen J., Wigzell H., Jondal M., Wahren B. 1989; Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gpl20 epitopes correlates with the uninfected status of children bom to seropositive mothers. Proceedings of the National Academy of Sciences, U.S.A. 86:1–5
    [Google Scholar]
23. Trifilieff E., Dubs M. C., Van Regenmortel M. H. V. 1991; Antigenic cross-reactivity potential of synthetic peptides immobilized on polyethylene rods. Molecular Immunology 28:889–896
    [Google Scholar]
24. Vialard J., Lalumiere N., Vernet T., Briedis D., Alkhatib G., Henning D., Levin D., Richardson C. 1990; Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the β-galactosidase gene. Journal of Virology 64:37–50
    [Google Scholar]